SEC Form 4 · accession 0001104659-26-105494
PALVELLA THERAPEUTICS, INC. · PVLA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher P Kiritsy
Director
Period of report
Sep 2, 2026
Accepted (ET)
Sep 4, 2026 · 4:05 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001583648
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 2, 2026 | M | 313 | $127.20 | A | 563 | D | |
| Common Stock | Sep 2, 2026 | S | 313 | $157.00 | D | 250 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1,F2 | $127.20 | Sep 2, 2026 | M | 313 | D | — | Sep 20, 2026 | Common Stock | 313 | 0 | D |
Explanation of responses
- F1The reported number of shares has been adjusted to reflect the impact of the Issuer's 1-for-80 reverse stock split, which became effective on April 23, 2024.
- F2The stock option is fully vested.